Drug Trial Radar · NCT01628731
Furosemide Versus Ethacrynic Acid in Children With Congenital Heart Disease
Last checked: Nov 20, 2026Latest source record: Jul 24, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
74
Actual
Start
Oct 2012
Primary completion
Jul 2013
Study completion Nov 2013
Sponsor
- Lead sponsor
- Bambino Gesù Hospital and Research InstituteAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 27, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, up to 10 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims to verify if ethacrynic acid continuous infusion is superior to furosemide continuous infusion in total urine output production during the first 24 post operative hours.
Conditions
- Fluid Overload
Interventions
furosemideDrug
furosemide, intravenous, continuous infusion, 0.2 mg/kg/h for 24 hours
ethacrynic acidDrug
ethacrynic acid, intravenous, continuous infusion, 0.2 mg/kg/h for 24 hours
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean total urine output production in the first post-operative dayTime frame: first 24 hours after Intensive Care Unit admission
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Bambino Gesù Hospital
Rome, Italy
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.